&w=3840&q=100)
More than 460 laid-off CDC employees receive reinstatement notices
More than 460 laid-off employees at the nation's top public health agency received notices on Wednesday that they are being reinstated, according to a union representing the workers.
The US Department of Health and Human Services confirmed reinstatement notices went out to the former Centres for Disease Control and Prevention employees, but provided few details.
About 2,400 CDC employees lost their jobs in a wave of cuts across federal health agencies in early April, according to a tally at the time.
Whole CDC programmes were essentially shut down, including some focused on smoking, lead poisoning, gun violence, asthma and air quality, and workplace safety and health. The entire office that handles Freedom of Information Act requests was shuttered. Infectious disease programmes took a hit, too, including programmes that fight outbreaks in other countries, labs focused on HIV and hepatitis in the US, and staff trying to eliminate tuberculosis.
An estimated 200 of the reinstated workers are based in the CDC's National Centre for HIV, Viral Hepatitis, STD, and Tuberculosis Prevention, HHS officials confirmed. Staffers at a CDC lab that does testing for sexually transmitted diseases are being brought back, said one CDC employee who was not authorised to discuss what happened and spoke to The Associated Press on condition of anonymity.
Also reinstated are an estimated 150 employees at the CDC's National Centre for Environmental Health, including people staffing a lab that works on lead poisoning, according to the union and employees.
Layoffs at federal agencies were challenged in lawsuits, with judges in some cases ordering federal agencies to halt terminations of employees.
Officials at HHS have never detailed how they made the layoff decisions in the first place. And they did not answer questions about why the notices went out, or how decisions were made about who to bring back.
HHS spokesperson Andrew Nixon said the agency was streamlining operations and that "the nation's critical public health functions remain intact and effective." "The Trump Administration is committed to protecting essential services whether it is supporting coal miners and firefighters through NIOSH, safeguarding public health through lead prevention, or researching and tracking the most prevalent communicable diseases," he said.
The reinstatements do not undo the damage being done by Kennedy and the Trump administration to federal public health, said members of Fired But Fighting, a group of affected CDC workers who have helped organise rallies in Atlanta. The most recent was in the rain on Tuesday, at which some attendees called for Kennedy to resign.
"Bringing a few hundred people back to work out of thousands fired is a start, but there are still countless programmes at CDC that have been cut, which will lead to increased disease and death," one of the group's founding members, Abby Tighe, said in a statement.
This is not the first time that employees at the Atlanta-based agency were told they were being terminated only to then be told to come back. After an earlier round of termination notices went out in February, about 180 CDC employees in March were told to come back.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Hindustan Times
an hour ago
- Hindustan Times
Why India needs inclusive blood donation policies now
Every year, thousands of Indians in critical medical need depend on life-saving blood transfusions. Yet, even as blood shortages persist, the country continues to enforce exclusionary policies that bar entire groups—particularly individuals from LGBTQIA+ communities and sex workers—from donating blood. These outdated bans are not just unscientific; they are discriminatory, rooted in stigma rather than evidence. It's time India reform its blood donation laws to reflect both medical advancements and human rights. India's blood donation guidelines, modeled after policies formed in the early days of the HIV/AIDS epidemic, impose blanket bans on certain populations. Men who have sex with men (MSM), trans persons, and sex workers are automatically disqualified, regardless of their individual sexual behavior, health status, or willingness to undergo testing. These guidelines paint entire communities with the same brush and are based on the assumption that persons from these communities indulge in unsafe sexual practices. Not only is this rooted in regressive moralistic codes, but it also takes the focus away from safe-sex, plurality of desire, and sexual health. Another key issue is the sidelining of advances in screening technologies and global best practices that enable safe blood collection from all individuals—regardless of identity. Modern blood banks use nucleic acid testing (NAT), which can detect HIV and other infections within days of exposure. NAT is revolutionising blood safety by detecting infections earlier than traditional serology-based tests. Unlike conventional methods, which may take weeks to detect infections, NAT identifies viral DNA or RNA within days of exposure, significantly reducing the risk of TTIs. For thalassemia patients, who undergo repeated transfusions, NAT can mean the difference between life-saving care and life-threatening complications. Excluding people based on identity rather than scientific risk factors not only violates their fundamental right to equality but also deprives the health system of potential donors. It perpetuates the harmful myth that LGBTQIA+ individuals and sex workers are inherently dangerous, further entrenching social stigma and institutional discrimination. India must urgently reform its blood donation guidelines in line with international scientific evidence and human rights norms. This begins by replacing identity-based deferrals with behavior-based screening protocols. All donors—regardless of sexual orientation, gender identity, or profession—should be assessed equally based on recent activities that may pose risk. The path forward requires a coordinated, multi-stakeholder strategy: India is at a crossroads. We can continue to let fear and misinformation dictate public health policy—or we can lead with science and compassion. We need a comprehensive review of India's blood donor eligibility criteria. This review must include consultations with medical experts, human rights advocates, and affected communities. India deserves a blood donation policy that reflects the values of equality, dignity, and modern science. This article is authored by Anubha Taneja Mukherjee, member secretary, Thalassemia Patients Advocacy Group and Rituparna Borah, co-founder and executive director, Nazariya Queer Feminist Resource Group.


The Hindu
2 hours ago
- The Hindu
Goal to end AIDS by 2030 ‘more off-track' after Trump cuts, UNAIDS head says
Donald Trump's cuts to HIV/AIDS programmes will further derail an already faltering plan to end the disease as a public health threat by 2030, UNAIDS Executive Director Winnie Byanyima said on Friday, June 13, 2025. With 1.3 million new infections in 2023, according to the latest data, the world was already 'off track,' Ms. Byanyima told journalists in South Africa, a country with the world's largest number of people living with HIV, at 8 million. 'Less funding means we will get more and more off-track,' she said in the main city of Johannesburg, after meeting President Cyril Ramaphosa to discuss Africa's HIV/AIDS strategy in light of the U.S. president slashing billions of dollars in foreign aid in February. 'We don't know yet what that impact will be, but impact there will be: ... already you see in several countries a drop in the number of people going to clinics,' Ms. Byanyima said. Before the cuts, prevention programmes had brought down new infections, she said, but they were "not coming down fast enough to reach our target of 2023." Now, with the shuttering of community prevention clinics across Africa, infections would surely rise, though it wasn't clear yet by how much, she said. The administration's decision to axe swaths of U.S. foreign aid has disrupted the supply of life-saving HIV treatments, with some countries facing potentially running out. In South Africa, about a fifth of whose HIV budget was U.S.-funded, testing and monitoring of HIV patients is already falling. Ms. Byanyima said even poor, indebted countries were managing to plug funding gaps, but called on other rich nations to step in. 'We're saying to the donors: this is one of the diseases ... without a cure, without a vaccine, yet we're seeing progress,' she said. 'If you've got a good success story, why drop it ... before you end it?'


NDTV
15 hours ago
- NDTV
Goal To End AIDS By 2030 "More Off-Track" After Trump Cuts: UNAIDS Head
Johannesburg: Donald Trump's cuts to HIV/AIDS programmes will further derail an already faltering plan to end the disease as a public health threat by 2030, UNAIDS Executive Director Winnie Byanyima said on Friday. With 1.3 million new infections in 2023, according to the latest data, the world was already "off track," Byanyima told journalists in South Africa, a country with the world's largest number of people living with HIV, at 8 million. "Less funding means we will get more and more off-track," she said in the main city of Johannesburg, after meeting President Cyril Ramaphosa to discuss Africa's HIV/AIDS strategy in light of the US president slashing billions of dollars in foreign aid in February. "We don't know yet what that impact will be, but impact there will be: ... already you see in several countries a drop in the number of people going to clinics," Byanyima said. Before the cuts, prevention programmes had brought down new infections, she said, but they were "not coming down fast enough to reach our target of 2023." Now, with the shuttering of community prevention clinics across Africa, infections would surely rise, though it wasn't clear yet by how much, she said. The administration's decision to axe swaths of US foreign aid has disrupted the supply of life-saving HIV treatments, with some countries facing potentially running out. In South Africa, about a fifth of whose HIV budget was US-funded, testing and monitoring of HIV patients is already falling. Byanyima said even poor, indebted countries were managing to plug funding gaps, but called on other rich nations to step in. "We're saying to the donors: this is one of the diseases ... without a cure, without a vaccine, yet we're seeing progress," she said. "If you've got a good success story, why drop it ... before you end it?"